The United Arab Emirates is preparing to begin the first clinical trials of Neuralink’s wireless brain chip outside the United States. Neuralink is a company founded by Elon Musk, and its brain chip is designed to help people who suffer from paralysis by allowing them to control devices with their thoughts. The goal is to improve their quality of life and give them more independence through advanced technology.
To carry out this important medical trial, the Department of Health in Abu Dhabi has joined hands with Cleveland Clinic Abu Dhabi and Neuralink. The trial program has been officially named UAE-PRIME. This is a big step forward for medical science and technology in the UAE and the wider region.
Mansoor Ibrahim Al Mansoori, the Chairman of the Department of Health Abu Dhabi, said that this development marks a major achievement in the field of life sciences. It shows how committed the UAE is to supporting innovation and bringing advanced healthcare solutions to the region.
Elon Musk, the founder of Neuralink, also confirmed the partnership and shared the news on the social media platform X, which was previously known as Twitter. This trial could open new doors for future treatments and research related to brain and nerve disorders, making the UAE a growing center for cutting-edge medical science.
